Company Filing History:
Years Active: 2022-2025
Title: Reinerus Gerardus Gieling: Innovator in Pharmaceutical Chemistry
Introduction
Reinerus Gerardus Gieling is a notable inventor based in Beuningen, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, holding two patents that showcase his innovative methods in drug preparation.
Latest Patents
Gieling's latest patents include a method for preparing 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine. This invention covers not only the method for preparing the compound but also intermediate compounds useful in its preparation. Additionally, it includes polymorphic form B of the compound with very high purity. Another significant patent is for the preparation of a 2,4,5-trisubstituted 1,2,4-triazolone, which provides methods for the preparation of Compound (I) and its crystalline form A.
Career Highlights
Throughout his career, Gieling has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His work in these organizations has contributed to advancements in drug development and formulation.
Collaborations
Gieling has collaborated with notable colleagues such as Philipp Rubenbauer and Johannes Platzek. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Reinerus Gerardus Gieling is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and collaborations. His contributions continue to impact the field positively.